Pump dysfunction and a dilated, relatively thin-walled ventricle typically characterize heart failure. Excessive cardiac myocyte lengthening is largely responsible for chamber dilatation in heart failure due to hypertension. As chamber dilatation and myocyte lengthening progress, the absence of growth in myocyte cross-sectional area impairs wall thickening and leads to elevated wall stress. Remodeling of LV myocyte shape in human hypertensives progressing to failure is similar to that in Spontaneously Hypertensive Heart Failure (SHHF) rats, which will be used in these studies. New data from SHHF rats show that Angiotensin type 1 (AT-1) receptor blockade reverses myocyte length and cross-sectional area back to normal or near normal values even when given just prior to the onset of heart failure. Hydralazine also normalized blood pressure, but there was no regression of myocyte hypertrophy. Hydralazine did, however, arrest progression of myocyte lengthening. The objective of this proposal is to determine the relative contributions of load and AT1 signaling in the remodeling of LV myocyte shape in the progression to failure. These two drugs and AT1 antisense therapy will be used in various combinations as tools to perturb the pathological growth process of LV myocytes in SHHF rats. This will allow investigators to determine the relative role of load (e.g. via membrane integrins and cytoskeleton) and signaling through the AT1 receptor in growth and regression of myocyte dimensions. At terminal experiments, LV hemodynamics, chamber dimensions (echos), and wall stress will be determined. Whole tissue and isolated myocytes will be used for determination of cellular dimensions and confocal analysis of membrane integrins, cytoskeleton, and G-protein signaling molecules.
Specific aims will examine the role of mechanical signaling and signaling through Angiotensin receptors in growth and regression of myocyte length and cross-sectional area. These studies will fill a critical void in our understanding of the cellular and molecular mechanisms underlying a key pathophysiologic cellular alteration that contributes to, or may actually cause, heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL062459-02S1
Application #
6500869
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Fakunding, John
Project Start
2000-07-01
Project End
2005-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
2
Fiscal Year
2001
Total Cost
$34,890
Indirect Cost
Name
University of South Dakota
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
929930808
City
Vermillion
State
SD
Country
United States
Zip Code
57069
Schultz, R L; Kullman, E L; Waters, R P et al. (2013) Metabolic adaptations of skeletal muscle to voluntary wheel running exercise in hypertensive heart failure rats. Physiol Res 62:361-9
Kisso, Bassel; Patel, Ankit; Redetzke, Rebecca et al. (2008) Effect of low thyroid function on cardiac structure and function in spontaneously hypertensive heart failure rats. J Card Fail 14:167-71
Kuzman, James A; O'Connell, Timothy D; Gerdes, A Martin (2007) Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 148:3477-84
Schultz, Rebecca L; Swallow, John G; Waters, Robert P et al. (2007) Effects of excessive long-term exercise on cardiac function and myocyte remodeling in hypertensive heart failure rats. Hypertension 50:410-6
Zhou, Jibin; Qu, Jiaxiang; Yi, Xian Ping et al. (2007) Upregulation of gamma-catenin compensates for the loss of beta-catenin in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 292:H270-6
Yi, Xian Ping; Zhou, Jibin; Huber, Lu et al. (2006) Nuclear compartmentalization of FAK and FRNK in cardiac myocytes. Am J Physiol Heart Circ Physiol 290:H2509-15
Liang, Qiangrong; Elson, Andrew C; Gerdes, A Martin (2006) p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats. J Card Fail 12:479-86
Tang, Yi-Da; Kuzman, James A; Said, Suleman et al. (2005) Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation 112:3122-30
Yi, Xian Ping; Zhou, Jibin; Baker, Justin et al. (2005) Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure. Anat Rec A Discov Mol Cell Evol Biol 282:13-23
Thomas, Tracy A; Kuzman, James A; Anderson, Brent E et al. (2005) Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure. Am J Physiol Heart Circ Physiol 288:H2118-22

Showing the most recent 10 out of 18 publications